Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BBNX NASDAQ:NVCR NASDAQ:PLSE NASDAQ:PRCT On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBBNXBeta Bionics$11.82+11.4%$10.58$8.80▼$32.71$526.72M3.29710,835 shs1.13 million shsNVCRNovoCure$17.96+0.3%$13.37$9.82▼$20.06$2.08B0.91.98 million shs848,886 shsPLSEPulse Biosciences$25.89+1.3%$22.02$12.56▼$27.98$1.79B1.63389,620 shs250,573 shsPRCTPROCEPT BioRobotics$29.00+0.2%$25.40$19.35▼$66.85$1.65B0.831.72 million shs1.12 million shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBBNXBeta Bionics0.00%+24.95%+3.41%-13.72%-24.04%NVCRNovoCure0.00%+2.16%+42.65%+58.10%+1.18%PLSEPulse Biosciences0.00%+5.46%+6.76%+20.87%+49.65%PRCTPROCEPT BioRobotics0.00%+11.03%+19.64%+6.34%-48.80%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBBNXBeta Bionics$11.82+11.4%$10.58$8.80▼$32.71$526.72M3.29710,835 shs1.13 million shsNVCRNovoCure$17.96+0.3%$13.37$9.82▼$20.06$2.08B0.91.98 million shs848,886 shsPLSEPulse Biosciences$25.89+1.3%$22.02$12.56▼$27.98$1.79B1.63389,620 shs250,573 shsPRCTPROCEPT BioRobotics$29.00+0.2%$25.40$19.35▼$66.85$1.65B0.831.72 million shs1.12 million shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBBNXBeta Bionics0.00%+24.95%+3.41%-13.72%-24.04%NVCRNovoCure0.00%+2.16%+42.65%+58.10%+1.18%PLSEPulse Biosciences0.00%+5.46%+6.76%+20.87%+49.65%PRCTPROCEPT BioRobotics0.00%+11.03%+19.64%+6.34%-48.80%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBBNXBeta Bionics 2.67Moderate Buy$20.0069.20% UpsideNVCRNovoCure 2.38Hold$27.2951.92% UpsidePLSEPulse Biosciences 2.33Hold$30.0015.87% UpsidePRCTPROCEPT BioRobotics 2.43Hold$41.4542.95% UpsideCurrent Analyst Ratings BreakdownLatest BBNX, NVCR, PLSE, and PRCT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/18/2026BBNXBeta Bionics Bank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetNeutral$23.00 ➝ $11.005/4/2026NVCRNovoCure Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetEqual Weight$13.50 ➝ $17.005/1/2026NVCRNovoCure EvercoreSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform4/30/2026PRCTPROCEPT BioRobotics Piper SandlerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOverweight$28.00 ➝ $35.004/22/2026BBNXBeta Bionics Leerink PartnersSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$25.00 ➝ $24.004/22/2026BBNXBeta Bionics Stifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$22.00 ➝ $20.004/21/2026BBNXBeta Bionics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (D-) ➝ Sell (E+)4/21/2026NVCRNovoCure Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/21/2026PLSEPulse Biosciences Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)4/21/2026PRCTPROCEPT BioRobotics Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/16/2026NVCRNovoCure WedbushSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral$18.00(Data available from 5/24/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBBNXBeta Bionics$110.24M4.78N/AN/A$6.09 per share1.94NVCRNovoCure$655.35M3.17N/AN/A$2.86 per share6.28PLSEPulse Biosciences$350K5,119.56N/AN/A$0.96 per share26.97PRCTPROCEPT BioRobotics$308.05M5.36N/AN/A$6.11 per share4.75Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBBNXBeta Bionics-$73.20M-$1.51N/AN/AN/A-60.27%-23.00%-20.55%N/ANVCRNovoCure-$136.23M-$1.53N/AN/AN/A-25.66%-50.82%-16.48%7/23/2026 (Estimated)PLSEPulse Biosciences-$72.78M-$1.10N/AN/AN/AN/A-86.67%-73.61%8/11/2026 (Estimated)PRCTPROCEPT BioRobotics-$95.57M-$1.82N/AN/AN/A-31.82%-27.70%-20.29%8/5/2026 (Estimated)Latest BBNX, NVCR, PLSE, and PRCT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/4/2026Q1 2026PLSEPulse Biosciences-$0.32-$0.27+$0.05-$0.27$0.25 millionN/A4/30/2026Q1 2026NVCRNovoCure-$0.5122-$0.62-$0.1078-$0.62$167.77 million$174.06 million4/29/2026Q1 2026PRCTPROCEPT BioRobotics-$0.55-$0.56-$0.01-$0.56$80.52 million$83.13 million4/21/2026Q1 2026BBNXBeta Bionics-$0.53-$0.49+$0.04-$0.49N/A$27.63 million2/26/2026Q4 2025NVCRNovoCure-$0.41-$0.22+$0.19-$0.22$174.40 million$174.35 million2/25/2026Q4 2025PRCTPROCEPT BioRobotics-$0.32-$0.53-$0.21-$0.53$93.70 million$76.38 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBBNXBeta BionicsN/AN/AN/AN/AN/ANVCRNovoCureN/AN/AN/AN/AN/APLSEPulse BiosciencesN/AN/AN/AN/AN/APRCTPROCEPT BioRoboticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBBNXBeta BionicsN/A10.699.67NVCRNovoCure0.712.902.70PLSEPulse BiosciencesN/A7.267.24PRCTPROCEPT BioRobotics0.156.735.51Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBBNXBeta BionicsN/ANVCRNovoCure84.61%PLSEPulse Biosciences76.95%PRCTPROCEPT BioRobotics89.46%Insider OwnershipCompanyInsider OwnershipBBNXBeta Bionics5.30%NVCRNovoCure5.52%PLSEPulse Biosciences74.00%PRCTPROCEPT BioRobotics6.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBBNXBeta Bionics29444.56 million42.20 millionN/ANVCRNovoCure1,605115.82 million109.43 millionOptionablePLSEPulse Biosciences14069.21 million18.00 millionOptionablePRCTPROCEPT BioRobotics43056.92 million53.16 millionOptionableBBNX, NVCR, PLSE, and PRCT HeadlinesRecent News About These CompaniesLisanti Capital Growth LLC Buys Shares of 35,890 PROCEPT BioRobotics Corporation $PRCTMay 24 at 6:00 AM | marketbeat.comDNB Asset Management AS Has $3.13 Million Stock Position in PROCEPT BioRobotics Corporation $PRCTMay 20, 2026 | marketbeat.comHead to Head Review: PROCEPT BioRobotics (NASDAQ:PRCT) versus Arrayit (OTCMKTS:ARYC)May 19, 2026 | americanbankingnews.com5 Robotics Stocks to Watch as Physical AI Builds Momentum (PRCT)...May 18, 2026 | marketbeat.comPROCEPT BioRobotics Corporation (NASDAQ:PRCT) Receives Average Recommendation of "Hold" from BrokeragesMay 18, 2026 | marketbeat.comPinnacle Associates Ltd. Takes Position in PROCEPT BioRobotics Corporation $PRCTMay 16, 2026 | marketbeat.comAUA Guidelines Strengthen Recommendation for Aquablation® TherapyMay 14, 2026 | globenewswire.comQ1 Results Say a Lot About Procept Biorobotics Corp (PRCT) Stock OutlookMay 12, 2026 | finance.yahoo.comPROCEPT BioRobotics Corporation (PRCT) Presents at Bank of America Global Healthcare Conference 2026 TranscriptMay 12, 2026 | seekingalpha.comPROCEPT BioRobotics (NASDAQ:PRCT) Trading Up 7.4% - Should You Buy?May 12, 2026 | marketbeat.comMitsubishi UFJ Asset Management Co. Ltd. Has $5.38 Million Position in PROCEPT BioRobotics Corporation $PRCTMay 12, 2026 | marketbeat.comPROCEPT BioRobotics Corporation $PRCT Shares Sold by Comerica BankMay 12, 2026 | marketbeat.comC WorldWide Group Holding A S Purchases 225,000 Shares of PROCEPT BioRobotics Corporation $PRCTMay 11, 2026 | marketbeat.comUBS Group AG Increases Position in PROCEPT BioRobotics Corporation $PRCTMay 9, 2026 | marketbeat.comHow The PROCEPT BioRobotics (PRCT) Investment Story Is Shifting After Q4 Miss And Guidance ResetMay 4, 2026 | finance.yahoo.comPROCEPT BioRobotics (PRCT)’s Growth Narrative Improves Following Aquablation Upgrade and HYDROS LaunchMay 1, 2026 | insidermonkey.comPROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & JuneApril 30, 2026 | globenewswire.comPROCEPT BioRobotics Corp (PRCT) Q1 2026 Earnings Call Highlights: Strong Revenue Growth Amidst ...April 30, 2026 | finance.yahoo.comPROCEPT BioRobotics (NASDAQ:PRCT) Shares Gap Up - Still a Buy?April 30, 2026 | marketbeat.comPROCEPT BioRobotics Corporation (PRCT) Q1 2026 Earnings Call TranscriptApril 30, 2026 | seekingalpha.comPROCEPT BioRobotics (NASDAQ:PRCT) Posts Quarterly Earnings Results, Misses Estimates By $0.01 EPSApril 29, 2026 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeBBNX, NVCR, PLSE, and PRCT Company DescriptionsBeta Bionics NASDAQ:BBNX$11.82 +1.21 (+11.40%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$12.00 +0.18 (+1.52%) As of 05/22/2026 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Beta Bionics, Inc. is a commercial-stage medical device company. It engages in the design, development, and commercialization of solutions for insulin-requiring people with diabetes. The company was founded by Edward R. Damiano on October 21, 2015 and is headquartered in Irvine, CA.NovoCure NASDAQ:NVCR$17.96 +0.06 (+0.34%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$17.76 -0.20 (-1.12%) As of 05/22/2026 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.Pulse Biosciences NASDAQ:PLSE$25.89 +0.33 (+1.29%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$25.88 -0.01 (-0.04%) As of 05/22/2026 07:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.PROCEPT BioRobotics NASDAQ:PRCT$29.00 +0.07 (+0.24%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$28.93 -0.07 (-0.23%) As of 05/22/2026 07:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/18 - 05/22 Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus? Workday Validates AI Flywheel: Stock Price Recovery Begins SpaceX IPO: Opportunity? Or the Ultimate Hype Trade? Overextended, e.l.f. Beauty Is Primed to Rebound in Back Half Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook NVIDIA Price Pullback? Don’t Count on It, Business Is Accelerating Palantir and Dell Build an AI OS for the Paranoid Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
